COPELIA: a 3-arm randomised phase II trial of weekly paclitaxel with or without cediranib or olaparib with cediranib in recurrent endometrial cancer
Clamp, A. R. ; Porter, C. ; White, A. ; Irving, A. ; Casbard, A. ; Hall, M. ; Eminowicz, G. ; George, A. ; Walther, A. ; Franklin, A. ... show 10 more
Clamp, A. R.
Porter, C.
White, A.
Irving, A.
Casbard, A.
Hall, M.
Eminowicz, G.
George, A.
Walther, A.
Franklin, A.
Abstract
Description
Date
2024
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Clamp AR, Porter C, White A, Irving A, Casbard A, Hall M, et al. COPELIA: a 3-arm randomised phase II trial of weekly paclitaxel with or without cediranib or olaparib with cediranib in recurrent endometrial cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2024 MAR;34(SUPPL_1):A17-A8. PubMed PMID: WOS:001443844800018. English.